Evidence map›Paper›PMID 40988919›Full record

ArticleFrontiers in artificial intelligence2025

Enhanced deep Convolutional Neural Network for SARS-CoV-2 variants classification.

Olaitan I Awe, Hesborn Obura, Charles Ssemuyiga, Evans Mudibo, Mike J Mwanga

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. TargetingFrontiers in bioinformatics · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Olaitan I AweAfrican Society for Bioinformatics and Computational Biology, Cape Town, South Africa.
Hesborn OburaDepartment of Biochemistry and Biotechnology, School of Pure and Applied Science, Pwani University, Kilifi, Kenya.
Charles SsemuyigaPharmaQsar Bioinformatics Firm, Kampala, Uganda.
Evans MudiboDepartment of Biochemistry and Biotechnology, School of Pure and Applied Science, Pwani University, Kilifi, Kenya.
Mike J MwangaDepartment of Biochemistry and Biotechnology, School of Pure and Applied Science, Pwani University, Kilifi, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Rapid and scalable classification of SARS-CoV-2 genomes from spike-gene sequences can support real-time genomic surveillance in contexts where whole-genome data or high-end computing resources are limited. Methods: We curated approximately 35,800 quality-filtered spike sequences spanning multiple clades and lineages and trained a hybrid CNN-BiLSTM model with standard regularization and class-imbalance handling. Model performance was benchmarked against Nextclade assignments and compared with classical machine-learning baselines. Results: Across 10 experimental runs, the model achieved a mean training accuracy of 99.74% ± 0.11, a validation accuracy of 99.00% ± 0.00, and a test accuracy of 99.91% ± 0.03. In benchmarking against the molecular epidemiology tool Nextclade, our model demonstrated superior performance, correctly identifying 100% of Omicron sequences, compared to 34.95% achieved by Nextclade. Saliency and feature attribution analyses highlighted recurrent spike substitutions consistent with known variant-defining mutations, as well as additional uncharacterized motifs with potential biological relevance. Discussion: These findings demonstrate that spike-only deep models can provide rapid and accurate clade or variant classification, while also yielding interpretable feature importance. Such models complement phylogenetic approaches in settings with constrained resources and enable efficient triage of samples for confirmatory whole-genome analysis, supporting more timely genomic surveillance.

Indexed as

Convolutional Neural Networksdeep learninggenomicsmachine learningSARS-CoV-2spike gene

Identifiers

PMID40988919
PMCPMC12450893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.